In CV disease, clopidogrel reduces nonfatal MI and MACE vs. aspirin but not stroke or mortality.
Ann Intern Med
; 175(12): JC137, 2022 12.
Article
em En
| MEDLINE
| ID: mdl-36469913
ABSTRACT
SOURCE CITATION Tasoudis PT, Kyriakoulis IG, Sagris D, et al. Clopidogrel monotherapy versus aspirin monotherapy in patients with established cardiovascular disease systematic review and meta-analysis. Thromb Haemost. 2022;1221879-87. 35577054.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Doenças Cardiovasculares
/
Acidente Vascular Cerebral
Limite:
Humans
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article